comparemela.com
  1. Home
  2. Live Updates
  3. Matt Zuga - Breaking News

Latest Breaking News On - Matt zuga - Page 1 : comparemela.com

Acumen Pharmaceuticals, Inc (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

United statesDan oconnellAlex braunDaniel oconnellMatt zugaNeena bitritto gargEric siemersDonanemab adcommPaul matteisColin bristowJim dohertyThomas shraderMatthew zugaWelcome to acumen pharmaceuticals full yearAmerican academy of neurology meeting in denverAcumen pharmaceuticals inc

Acumen Pharmaceuticals, Inc (NASDAQ:ABOS) Q1 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Acumen Pharma Q1 2023 Conference Call and Webcast. At this time all participants are in a listen-only mode.

Tom shraderEric siemersMatt zugaAlex braunDaniel oconnellJudah frommerColin bristowCharlie yangDan oconnellAcumen pharmaceuticals incCredit suisseHealth photoAdvisory committeeAcumen pharmaceuticalsCall transcript mayDanielo connell

Acumen Pharmaceuticals, Inc (NASDAQ:ABOS) Q4 2022 Earnings Call Transcript

Operator: Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2022 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Vastra gotalands lanAlex braunPaul matteisMatt zugaDan oconnellTom shraderDaniel oconnellEric siemersWelcome to acumen pharmaceuticals full yearData monitoring committeeAcumen pharmaceuticals incSilicon valley bankAcumen pharmaceuticalsCall transcript marchAcumen pharmaceuticals full yearDano connell

Acumen Pharmaceuticals, Inc (ABOS) Q2 2022 Earnings Call Transcript

ABOS earnings call for the period ending June 30, 2022.

San diegoUnited statesLiean schenckMatt zugaJohn woolfordEli lillyPaul matteisGeoff meachamAmerica merrill lynchDaniel oconnellKent iversonTom shraderJeff sevignyDan oconnellLonza biologicsJudah frommer

Acumen Pharmaceuticals, Inc (ABOS) Q1 2022 Earnings Call Transcript

ABOS earnings call for the period ending March 31, 2022.

Dan oconnellMatt zugaPaul matteisColin bristowEric siemersJohn woolfordBeta oligomerAcumen pharmaceuticals incStifel financial corpAcumen pharmaceuticalsDano connellChief executiveAmyloid beta oligomer hypothesisFinancial officerChief business

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.